All News about Morphosys Ag ADR
![](https://ml.globenewswire.com/media/54cbaf70-16fe-4ac1-8956-c2d21ff8ae45/small/firm-logo-with-investor-law-firm-jpg.jpg)
![](https://investorplace.com/wp-content/uploads/2022/03/global_investing_1600-1024x576.png)
![](https://mms.businesswire.com/media/20240712469608/en/1537788/22/MOR-Logo-blau-RGB.jpg)
From MorphoSys AG
Via Business Wire
![](https://ml.globenewswire.com/media/54cbaf70-16fe-4ac1-8956-c2d21ff8ae45/small/firm-logo-with-investor-law-firm-jpg.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_2.jpeg?width=1200&height=800&fit=crop)
MorphoSys: Q4 Earnings Insights
March 13, 2024
Via Benzinga
![](/next-assets/images/schema-image-default.png)
Earnings Outlook For MorphoSys
March 12, 2024
Via Benzinga
![](https://ml.globenewswire.com/media/54cbaf70-16fe-4ac1-8956-c2d21ff8ae45/small/firm-logo-with-investor-law-firm-jpg.jpg)
![](https://mms.businesswire.com/media/20240620648176/en/1567526/5/Firm_Logo-with_Investor_Law_Firm.jpg)
![](https://mms.businesswire.com/media/20240619218783/en/1537788/22/MOR-Logo-blau-RGB.jpg)
![](https://edge-cdn.isdr.io/accesswire/Accesswire_256x256.png )
![](https://edge-cdn.isdr.io/accesswire/Accesswire_256x256.png )
![](https://cdn.benzinga.com/files/images/story/2023/movers_image_18.jpeg?width=1200&height=800&fit=crop)
Via Benzinga
![](https://investorplace.com/wp-content/uploads/2022/05/earnings-season-1600.png)
![](https://mms.businesswire.com/media/20240429848432/en/1537788/22/MOR-Logo-blau-RGB.jpg)
MorphoSys AG Reports First Quarter 2024 Financial Results
April 29, 2024
From MorphoSys AG
Via Business Wire
![](https://cdn.benzinga.com/files/images/story/2024/04/29/laboratory-217041-1280_0.jpeg?width=1200&height=800&fit=crop)
![](https://edge-cdn.isdr.io/accesswire/Accesswire_256x256.png )
![](https://cdn.benzinga.com/files/images/story/2024/04/23/pharma-lab-worker-ai.png?width=1200&height=800&fit=crop)
![](https://mms.businesswire.com/media/20240411351300/en/1537788/22/MOR-Logo-blau-RGB.jpg)
![](https://edge-cdn.isdr.io/accesswire/Accesswire_256x256.png )
![](https://edge-cdn.isdr.io/accesswire/Accesswire_256x256.png )
![](https://mms.businesswire.com/media/20240313374964/en/1537788/22/MOR-Logo-blau-RGB.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/earnings_image.jpeg?width=1200&height=800&fit=crop)
![](https://staticx-tuner.zacks.com/images/articles/main/f5/284.jpg)
![](https://investorplace.com/wp-content/uploads/2020/10/child-cancer-patient.jpg)
![](https://investorplace.com/wp-content/uploads/2019/07/biotech1600molecule.jpg)
![](https://cdn.benzinga.com/files/images/story/2024/Novartis_0.jpeg?width=1200&height=800&fit=crop)
![](https://www.investors.com/wp-content/uploads/2018/04/STOCK-Novartis-02-shutter.jpg)
![](https://investorplace.com/wp-content/uploads/2021/12/shutterstock_1726134715.png)
![](https://cdn.benzinga.com/files/images/story/2024/02/05/image32.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2024/people-95715-1280.jpeg?width=1200&height=800&fit=crop)
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.